PATH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction STRW Q1 2026 Earnings Earnings Beat Expectations Amidst Modest Stock Decline Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market Oxford Industries Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter HLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds